TB

This document outlines the United States Government's global TB strategy.

This brief online course allows users to test their knowledge regarding the Xpert MTB/RIF assay.

This document presents guidance on the design and implementation of surveys and surveillance systems to measure the burden and trends of drug-resistant tuberculosis.

This facilitators’ guide for training community health workers and community volunteers is intended for training in tuberculosis (TB) and integration of TB prevention and care services into community-based activities.

This fact sheet provides general information regarding TB infection and TB disease.

Also available in the following languages: Amharic, Arabic, Cape Verdean Creole, Chinese, French, Gujarati, Haitian Creole, Hindi, Khmer, Nepali, Portuguese, Russian, Somali, Spanish, Swahili, Tagalog, and Vietnamese.

This slide set was developed as an accompaniment to Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection, a joint statement by CDC and the American Thoracic Society, and subsequent updates. The slide set provides an overview of the current recommendations for the testing and treatment of latent tuberculosis.

This video provides information on how to administer directly observe therapy (DOT).

This quick reference guide provides information on how to correctly administer and read a tuberculin skin test (TST).

This website contains resources, materials, and links to latent TB infection and U.S. Preventive Services Task Force (USPSTF) materials.

The purpose of this document is to provide guidance for clinicians, nurses, and hospital infection preventionists on the use of the Xpert MTB/RIF assay when making decisions to discontinue airborne infection isolation for persons with suspected, infectious pulmonary TB.